Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Xenical
Active Ingredient: Orlistat 120mg
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche Ltd, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Prodotti SpA, Segrate, Milan, Italy
Dated this 15th day of May 2004.
DAVID NICHOLSON, National Services Manager, acting as Deputy Director-General, Public Health, for the period 5 May 2004 to 28 May 2004 (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).